TY  - BOOK
AU  - Benzi,Andy
AU  - Wuestenberghs,Fabien
AU  - Vitton,Véronique
AU  - Chambaz,Marion
AU  - Roman,Sabine
AU  - Benech,Nicolas
AU  - Dainese,Raffaella
AU  - Takoudju,Céline
AU  - Jouët,Pauline
AU  - Raynaud,Jean-Jacques
AU  - Gourcerol,Guillaume
AU  - Melchior,Chloé
AU  - Mion,François
TI  - Recommendations from the French Neurogastroenterology Group for the diagnosis and management of small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO)
PY  - 2025///.
							
N1  - 8
N2  - The French Neurogastroenterology Group (GFNG) initiated the drafting of recommendations for the diagnosis and management of small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) in adults. A working group developed a total of 25 proposals based on the most recent data from the international scientific literature, addressing the following topics: definition, symptoms, risk factors, diagnostic modalities, and therapeutic approaches. Each statement was assessed using the GRADE methodology to determine its level of evidence (“high,” “moderate,” “low,” or “expert opinion”) and, where applicable, a level of recommendation (“strong,” “moderate,” “weak,” or “very weak”). The proposals were submitted to 22 experts for a two-round vote, in accordance with the Delphi method, resulting in consensus—with over 80% agreement— for 19 proposals on SIBO and 3 on IMO. One proposal on SIBO and 2 on IMO failed to reach consensus, reflecting the complexity of these conditions
UR  - https://stm.cairn.info/journal-hepato-gastro-oncologie-digestive-2025-6-page-528?lang=en&redirect-ssocas=7080
ER  -